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The tight junction forms a barrier that limits paracellular movement of water, ions, and macromolecules. The permeability properties of this
barrier are regulated in response to both physiological and pathophysiological stimuli, and this regulation has been modeled by pharmacological
agents. Although it is now known that vesicular traffic plays important roles in tight junction assembly, the molecular mechanisms by which
vesicular traffic contributes to tight junction regulation remain to be defined. This review summarizes recent progress in understanding
mechanisms and pathways of tight junction protein internalization and the relevance of these to tight junction regulation.
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Complex organisms are composed of multiple organs that
serve unique functions. This requires a relatively constant in-
ternal milieu as well as the presence of some compartments in
which fluid composition is markedly different from the overall⁎ Corresponding author. Tel.: +1 773 702 2433; fax: +1 773 834 5251.
E-mail address: jturner@bsd.uchicago.edu (J.R. Turner).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.07.027milieu. The maintenance of these distinct tissue compartments
with defined fluid composition requires barriers to free dif-
fusion. Plasma membranes of individual cells provide some
barrier function, but intercellular junctions are needed to seal the
paracellular space between cells. Such junctions are present in
epithelial and endothelial cells that line surfaces in many tissues
within the gastrointestinal, respiratory, and urinary tracts as
well as the integument. In each of these tissues, tight junctions
join adjacent epithelial or endothelial cells to restrict diffusion,
Fig. 1. Molecular composition of the tight junction. Tight junctions consist of
three main groups of proteins. They are transmembrane proteins, e.g. claudins
and occludin, cytoplasmic plaque proteins, e.g. ZO-1, ZO-2, ZO-3, and cingulin,
and cytoskeletal and signaling proteins, e.g. actin, myosin II, and PKCζ. These
proteins interact to maintain tight junction structure.
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physiological and pathophysiological situations require ex-
change of solutes and water between compartments. This de-
mands that the tight junction be able to rapidly regulate barrier
function in response to appropriate stimuli [2–4]. While great
progress has been made in understanding these processes, the
molecular mechanisms by which the tight junction is regulated
remains a fundamental question in cell biology, physiology, and
medicine.
2. Tight junction structure and molecular composition
The tight junction is the most luminal component of the apical
junctional complex, which also includes the adherens junction
[5]. The latter is composed of cadherin proteins, E-cadherin in
epithelia, that form calcium-dependent intercellular bonds [6,7].
Tight junction assembly and maintenance typically requires the
presence of intact adherens junctions, though the converse is not
true [7–9]. In addition, the structural and functional integrity of
the tight junction depends on the presence of a perijunctional
ring of actin and myosin which can also contribute to the reg-
ulation of paracellular permeability [3,10].
As initially defined by transmission electron microscopy, the
tight junction is a site where membranes of adjacent cells appear
to nearly fuse [11]. Freeze-fracture electron microscopy shows
the tight junction as multiple continuous, anastomosing strands
composed of intramembranous particles [12]. Two models have
been proposed to explain the chemical nature of the tight
junction strands: the lipid model and the protein model. The lipid
model proposes that individual tight junction strands represent
pairs of inverted cylindrical micelles with the polar head groups
of the lipids directed inward and the hydrophobic tails immersed
in the lipid matrix of the plasma membranes of both contacting
cells [13]. While this model has been generally discarded, the
recognition that tight junction membrane domains are enriched
in cholesterol and sphingolipids provides some support for the
concept that tight junctions are formed, in part, by specialized
lipid-based structures. The protein model of tight junction struc-
ture (Fig. 1) proposes that strands are formed by interactions
between integral membrane proteins and peripheral membrane
proteins [5,14]. Identification of tight junction integral mem-
brane proteins, particularly the observation that several of these
can form strands of intramembranous particles, provides strong
support for the protein model [15–18].
Occludin was the first transmembrane tight junction protein
to be discovered [19]. Freeze-fracture immunoelectron micros-
copy showed occludin to be a component of the tight junction
strands, and, in fibroblasts, occludin expression induced for-
mation of tight junction-like strands [18,20,21]. Moreover, ex-
pression of occludin in fibroblasts induced cell adhesion [20].
Despite this and additional in vitro functional data and in vivo
correlative data, the role of occludin in tight junction function
has fallen into question because occludin-deficient embryonic
stem cells have the capability to develop tight-junction strands
indistinguishable from normal strands [22] and occludin-null
mice are viable and have normal-appearing intestinal tight junc-
tions [23]. This, however, remains an area in need of furtherstudy, as a plethora of in vitro studies do suggest that occludin
has important functional roles.
The observation that occludin is not absolutely required for
development of polarized epithelial cells bearing normal tight
junctions led to a search for additional tight junction proteins.
This resulted in identification of the claudin family of proteins
[15]. Over 20 claudin family members have been identified in
humans where they are localized to tight junction strands and
along lateral membranes of epithelial cells [16]. Either indi-
vidually or in combination with other family members claudin
proteins define the charge selective permeability of the tight
junction [24]. For example, mutations in claudin-16 prevent
paracellular Mg2+ reabsorption in the renal tubule, resulting in
the Mg2+-wasting disease of familial hypomagnesemia. Inter-
estingly, most claudin-16 mutations result in trafficking defects
that limit incorporation of this protein into tight junctions [25].
General trafficking of claudin proteins to the tight junction also
requires ZO-1 and ZO-2, which may serve to form a complex
linking claudins, occludin, actin, and other tight junction pro-
teins to one another [26,27].
ZO-1 is the prototype of many peripheral membrane proteins
localized to the cytoplasmic face of the tight junction [28,29].
Many of these proteins are described as “scaffold” proteins
because they interact with both transmembrane and cytoskeletal
proteins. Thus, they are thought to provide some essential part of
the regulatory control the perijunctional actomyosin ring exerts
on the tight junction, although the details of this are not well
understood. In addition to ZO-1, which includes three PDZ
domains and an actin binding region, tight junction scaffold
proteins include ZO-2, ZO-3, cingulin, andMUPP1 [28,30–33].
A number of kinases, most prominently PKCζ, have also been
localized to the tight junction [34–36].
3. Role of vesicular traffic in tight junction assembly
and regulation
Early studies using the calcium switch model of accelerated
tight junction assembly showed that apical membrane compo-
nents accumulated in intracellular vesicles termed the vacuolar
Table 1
Mechanisms of stimulus-induced regulation of tight junction structure
Stimulus Cell line/tissue Endocytic pathway Signaling event Cytoskeletal event Vesicle content Reference
E. coli CNF-1 toxin T84 Caveolae RhoA, rac1, and cdc42 activation,
MLC dephosphorylation
Occludin, claudin-1,
JAM-A, ZO-1
[49]
Enteropathogenic
E. coli infection
T84 Ezrin
phosphorylation
MLC phosphorylation Occludin, claudin-1 [47,48,58,83]
Enteropathogenic
E. coli infection
Mouse jejunum
and colon
Occludin [46]
Clostridium difficile
toxins
T84 Caveolae PKC a/β
activation
Rho GTPase inactivation Occludin, ZO-1 [84–86]
Calcium depletion T84 Clathrin Adherens junction
disruption
Myosin ATPase activation Occludin, JAM-A,
claudin-1, ZO-1
[50,54]
IFN-γ T84 Macropinocytosis Rho kinase Myosin ATPase activation Occludin, JAM-A,
claudin-1
[55]
Helicobacter pylori
CagA
MDCK c-Src inactivation Cortactin dephosphorylation ZO-1, JAM [87,88]
Latrunculin A MDCK Caveolae Actin depolymerization Occludin [53]
TNF Caco-2 MLCK activation MLC phosphorylation Occludin, claudin-1 [45]
LIGHT Caco-2 Caveolae MLCK activation MLC phosphorylation Occludin, claudin-1 [74]
T cell activation, TNF,
or LIGHT
Mouse jejunum MLCK activation MLC phosphorylation Occludin, JAM-A [75,76]
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centration was increased to a level sufficient to allow adherens
junction assembly, tight junction assembly also occurred and
VACs fused with the newly-developed apical membrane. Iden-
tification of individual tight junction proteins and preparation of
antisera to these led to the conclusion that VACs also contain
some tight junction proteins [38,39]. Thus, regulated membrane
traffic, which depends on the prior assembly of adherens junc-
tions, appears to be required for tight junction assembly. One
exception to this may be the partial polarization of solitary
epithelial cells that occurs after activation of STRAD, which
activates the serine-threonine kinase mutated in Peutz–Jegher's
syndrome, LKB1 [40]. It is notable that STRAD activation only
causes incomplete targeting of actin and the cytoplasmic pro-
teins ZO-1 and villin to appropriate locations, while some mem-
brane proteins, such as E-cadherin, are not targeted at al. Data on
the effect of STRAD activation on occludin and claudin local-
ization have not been reported.
4. Endocytosis of tight junction proteins occurs commonly
Given the critical role of membrane traffic in tight junction
assembly, it is not surprising that endocytosis of tight junction
components also occurs. For over 30 years, electron micro-
graphs have documented the presence of tight junction remnants
in cytosolic vesicles, both in cultured cells and in tissues, sug-
gesting that vesicular traffic might be a common mechanism for
modification of tight junctions in response to physiological and
pathological stimuli [12,41–44]. More recently, occludin in-
ternalization has been shown in vitro and in vivo in response
to cytokines, bacteria, toxins, and calcium depletion [45–51]
(Table 1). We recently visualized the process of occludin in-
ternalization after TNF treatment in real time in vivo using mice
expressing an EGFP-occludin fusion protein [52]. In addition to
these pathological conditions, endocytosis is also seen in phys-
iological conditions and with other type of integral proteins. Forexample, claudin-3 internalization occurs during movement of
epithelial cells within a monolayer [42].
5. Mechanisms of tight junction protein internalization
The mechanisms that regulate tight junction protein in-
ternalization have only been studied in detail over the last
decade as transmembrane tight junction proteins were identified
and means of detecting individual tight junction proteins have
become available. The latter include a wide array of commercial
antisera and well-characterized fluorescent fusion constructs of
representative tight junction proteins [53]. These tools and
growing interest in the role of tight junction disruption in path-
ophysiology, particularly in the gastrointestinal tract, have
spawned a large number of studies evaluating tight junction
protein trafficking in response to physiological, pharmacolog-
ical, and pathophysiological stimuli. Remarkably, all three clas-
sic pathways of endocytosis have been reported to be involved
in tight junction protein internalization, depending on the stim-
ulus used (Fig. 2).
For example, calcium depletion, a non-physiological stim-
ulus that may trigger tight junction disassembly by releasing
intercellular cadherin interactions, causes internalization of both
adherens and tight junction proteins [50,54]. Immunofluores-
cent studies suggest that several proteins, including E-cadherin,
β-catenin, occludin, and junctional adhesion molecule-A
(JAM-A). These proteins co-localize with one another as well
as α-adaptin, a marker of clathrin-mediated endocytosis [50],
suggesting that all are internalized via clathrin-coated vesicles.
The adherens and tight junction proteins do not appear to re-
main in clathrin-coated vesicales, as co-localization with mark-
ers of early endosomes, such as rab5 and EEA1, is also seen.
The colocalization in these early endocytic compartments sug-
gests that the intact complex may be internalized. E-cadherin,
β-catenin, occludin, and JAM-A also co-localized with
the basolateral marker syntaxin-4, but only E-cadherin and
Fig. 2. Stimulus-induced endocytosis of tight junction proteins. Calcium de-
pletion causes clathrin-mediated endocytosis of adherens junction (E-cadherin)
and tight junction (claudin, occludin) proteins. TNF core family members
caused caveolae-mediated endocytosis of occludin, but not other proteins. Both
pathways involve actomyosin-dependent processes. The fate of these vesicles,
including whether they fuse with lysosomes, resulting in protein degradation, or
with recycling endosomes, with protein trafficking back to the tight junction,
remains to be defined.
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that, once internalized, there is some sorting of junction pro-
teins as well as mixing of basolaterally-derived and junction-
derived endosomes, but that this may be differentially-regulated
for tight junction and adherens junction proteins [50]. In support
of this hypothesis, tight junction and adherens junction proteins
appear to segregate from one another in subapical endosomes 1
h after calcium depletion. Consistent with the proposed role of
clathrin-mediated endocytosis, agents that grossly perturb
endocytosis, including acidic and hyperosmotic media, were
each able to prevent occludin and E-cadherin endocytosis after
calcium depletion. Further support of this interpretation is
provided by the failure to detect co-localization of occludin or E-
cadherin with caveolin-1 or internalized dextran, or to prevent
occludin or E-cadherin internalization with cholesterol depletion
or PI3-kinase inhibition, which interfere with caveolar endocy-
tosis and macropinocytosis, respectively. Thus, it appears clear
that clathrin-mediated endocytosis of tight junction and
adherens junction components occurs after calcium depletion
[50]. While it remains to be determined if blockade of clathrin-
mediated endocytosis can prevent the loss of tight junction
barrier function after calcium depletion, inhibition of myosin II
ATPase with blebbistatin, which also prevents occludin and E-
cadherin internalization, prevents barrier loss to a limited degree
[54]. However, as might be expected of a drug that interferes
with actomyosin function, blebbistatin also disrupts the tight
junction barrier, even in the presence of extracellular calcium,
thereby complicating interpretation of these data.
Interestingly, blebbistatin has also been reported to prevent
the occludin internalization induced by interferon-γ (IFN-γ) in
cultured intestinal epithelial monolayers [55]. Unlike the en-docytosis of tight junction and adherens proteins seen after
calcium depletion, IFN-γ induces macropinocytosis-like endo-
cytosis of tight junction proteins [56]. These co-localize with the
early endosomes marker EEA1 as well as markers of recycling
endosomes, rab4 and rab11, but not lysosomal markers such as
LAMP1. It thus appears that, while the general mechanisms of
tight junction protein internalization induced by calcium
depletion or IFN-γ in cultured intestinal epithelia differ, both
involve actomyosin-dependent processes.
Unlike calcium depletion and IFN-γ treatment, the Escheri-
chia coli toxin cytotoxic necrotizing factor-1 (CNF-1), which
activates Rho GTPases, seems to induce occludin internalization
into caveolin-1-positive structures [49]. This suggests that such
endocytosis occurs via caveolae, which are thought to form from
lipid rafts and concentrate cargo by nature of the specialized lipid
composition of these domains. CNF-1 also induces redistribu-
tion of claudin-1, JAM-A, and ZO-1 though, unlike calcium
depletion, these tight junction proteins were not co-localized
with occludin and adherens junctions were not disrupted. While
internalized occludin did not co-localize with LAMP1, some
occludin did co-localize with EEA1 and rab11. The quantitative
significance of this was not evaluated, but it does raise the pos-
sibility that occludin, and perhaps other tight junction proteins,
could be recycled to the tight junction after stimulus-induced
internalization. CNF-1 also induced actin reorganization and
loss of the pool of phosphorylated myosin II regulatory light
chain (MLC) normally present at the tight junction [49,57].
Thus, although intermediates that trigger occludin internaliza-
tion or barrier loss have not been defined, it appears that the
cytoskeleton is also involved in this caveolae-mediated tight
junction protein endocytosis. Although the pathway of endocy-
tosis has not been characterized, the noninvasive diarrheal path-
ogen enteropathogenic E. coli, also causes occludin endocytosis
in vitro and in vivo [46–48]. A large part of this barrier loss is
also regulated by cytoskeletal mechanisms, at least in vitro
[58,59].
6. Direct microfilament perturbation causes tight junction
protein internalization
Consistent with a central role of actomyosin in regulating
barrier function, direct perturbation of filamentous actin with the
depolymerizing drug latrunculin A causes tight junction dis-
ruption [53,60–63]. Epithelial monolayers expressing fluores-
cent fusion constructs of occludin, claudin-1, ZO-1, and β-actin
and real time fluorescence microscopy with simultaneous mea-
surement of barrier function demonstrated that only occludin
internalization correlated with latrunculin A-induced barrier
loss [53]. While claudin-1 and ZO-1 were redistributed after
latrunculin A treatment, these changes occurred after the bulk of
barrier loss, suggesting a secondary event not directly related to
barrier loss. Further real time imaging using monolayers ex-
pressing red fluorescent-tagged occludin and either green
fluorescent-tagged caveolin-1 or yellow fluorescent-tagged
clathrin light chain showed that latrunculin A-induced occludin
internalization occurred through caveolin-1-positive structures,
but not occludin-positive structures. Morphometric and kinetic
Fig. 3. Occludin is internalized in vivo after immune activation. T cells were
activated in vivo by intraperitoneal injection of anti-CD3 antibody. This resulted
in TNF-dependent occludin (red) internalization. F-actin (green) and nuclei
(blue) are shown for reference.
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caveolin-1-positive compartments, relatively little internalized
occludin trafficked to EEA1-positive endosomes or LAMP1-
positive lysosomes [53]. Moreover, inhibition of endocytosis
by cooling to 14 °C, hyperosmotic media prevented occludin
internalization and barrier loss. Disruption of lipid rafts by
cholesterol depletion, which interferes with endocytosis via
caveolae, also prevented occludin internalization, but inhibition
of Na+H+-exchange, PI3-kinase, or clathrin assembly were all
without effect [53]. Thus, pharmacological actin depolymeriza-
tion induces occludin internalization via caveolae and interrup-
tion of this process prevents barrier loss. However, these data do
not show that occludin is functionally important, only that
occludin is a sensitive marker of the endocytic events that ac-
company actin depolymerization-induced barrier loss. Nonethe-
less, common themes in tight junction disruption by disparate
stimuli appear to include modification of the perijunctional
actomyosin ring and occludin internalization by one of several
different endocytic pathways.
7. Relationship of tight junction protein internalization to
pathophysiological barrier loss
In recent years, intestinal epithelial barrier loss induced by
TNF has received a great deal of attention [35,41,64]. This is, in
part, due to the fact that intestinal barrier function is disrupted in
Crohn's disease and that TNF neutralization is able to induce
disease remission and restore barrier function in patients [65–
68]. Thus, it appears that TNF-induced barrier dysfunction may
be a critical contributor to human disease [41,67]. Although it
had been known for several years that tumor necrosis factor
could also induce barrier loss in cultured epithelial monolayers
[69,70], the discovery that MLC phosphorylation was markedly
increased by TNF represented a major breakthrough in un-
derstanding the mechanisms of this process [59]. In addition to a
correlation between MLC phosphorylation and barrier loss,
specific inhibition of MLC kinase reversed in vitro barrier loss
induced by TNF [59]. This TNF-induced barrier loss was as-
sociated with enzymatic as well as transcriptional activation of
MLC kinase [45,71–73]. Moreover, occludin and claudin-1
internalization were induced by TNF[45].
Although the mechanisms of in vitro TNF-induced occludin
internalization have not been studied in detail, a TNF core
family member, LIGHT (lymphotoxin-like inducible protein
that competes with glycoprotein D for herpes virus entry on
T cells), also induces MLC kinase-dependent occludin and
claudin-1 internalization [74]. Detailed morphometric analysis
showed that the progressive decreases in tight junction barrier
function correlate with increased numbers of intracellular
occludin-containing vesicles [74]. These occludin vesicles
also contained caveolin-1, but not clathrin heavy chain. More
importantly, inhibition of caveolar endocytosis, but not clathrin-
mediated endocytosis or macropinocytosis, prevented occludin
internalization and barrier loss [74]. Since inhibition of caevolar
endocytosis did not prevent MLC phosphorylation, but MLC
kinase inhibition prevented occludin endocytosis and barrier
loss, these data also show that MLC phosphorylation precedesand is necessary for occludin internalization and barrier dys-
function, but that caveolar endocytosis is not required for MLC
phosphorylation. Thus, like the pharmacological stimulus
latrunculin A, caveolar endocytosis seems to be critical to this
cytokine-induced barrier dysfunction.
8. In vivo analysis of stimulus-induced barrier loss and
tight junction reorganization
Until recently, analysis of tight junction protein endocytosis
in response to defined stimuli had only been studied in vitro.
However, recent work has shown that either T cell activation or
direct administration of recombinant TNF or LIGHT induces
occludin internalization and barrier dysfunction in mice [75,76].
As predicted by some of the in vitro data, this was associated
with epithelial MLC phosphorylation and either genetic or
pharmacological inhibition of intestinal epithelial MLC kinase
prevented both occludin internalization and barrier dysfunction
[75]. In an observation only possible in an intact in vivo system,
barrier dysfunction induced by T cell activation or TNF admin-
istration resulted in net intestinal water secretion, i.e. diarrhea,
which was also prevented by either genetic or pharmacological
MLC kinase inhibition [75,76]. In contrast to TNF, LIGHT,
which induced similar MLC kinase-dependent barrier dysfunc-
tion, actually enhanced water absorption [76]. This difference
was due to the second effect of TNF, downregulation of epi-
thelial Na+ absorption, which was not induced by LIGHT. Thus,
in addition to demonstrating that MLC kinase-dependent barrier
dysfunction is necessary for cytokine-driven acute diarrhea to
occur in vivo, these data also demonstrate that the barrier
dysfunction is only part of the story. Water can flow in either
direction through tight junctions in which cytokines have
caused increased permeability. The determination of the di-
rection of water flow depends on osmotic gradients generated
by active transepithelial transport [76,77].
The in vivo studies also show that, despite MLC kinase-
dependent occludin internalization (Fig. 3), endocytosis of ZO-
1, claudins, and adherens junction proteins did not occur [75].
Occludin endocytosis without claudin endocytosis is similar to
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the other in vitro studies which generally showed internalization
of occludin along with claudin, JAM-A, or other tight junction
proteins. While it remains to be characterized, these disparate
results may well reflect the difference between acute or transient
stimuli and chronic stimuli. In the case of latrunculin A, claudin-1
redistribution was seen at later time points, after most barrier
function losses had occurred. Thus, if only the endpoint, rather
than many intermediate time points, were assessed, the results
might have been mistakenly interpreted to imply that claudin
redistribution coincides with barrier loss. In the in vivo example
given a pulse of cytokine release occurs and then rapidly dimin-
ishes. Thus, it may be that prolonged cytokine simulation, as
occurs in chronic disease, may induce internalization of claudin
proteins as well as occludin. This, in fact, has recently been
observed in epithelia from patients with Crohn's disease [78–80].
The temporal correlation of occludin internalization with
initial barrier loss also suggests that occludin may be a critically
important functional component of the tight junction. However,
reports that occludin knockout mice have normal intestinal
barrier function have been interpreted to imply that occludin
does not play an important role in tight junction structure or
regulation [23,81]. While no in vivo data are available to refute
this interpretation, the fact remains that abundant in vitro data
clearly support a functional regulatory role for occludin. These
include data from epithelial cells in which occludin expression
was suppressed by stably expressing short interfering RNA [82].
Thus, it may be that the few studies of intestinal function in
occludin knockout mice have failed to show a functional deficit
because the mice have not been subjected to stress or, alter-
natively, because there are compensatory changes in expression
of another, as yet unidentified, protein. Clearly, this is an area in
which more work is needed.
9. Concluding comments
It is now clear that vesicular traffic plays an important role in
regulating tight junction structure and function in response to a
wide variety of stimuli. The demonstration that this process also
occurs in vivo, and is specifically-related to intestinal disease,
makes it essential that these observations be defined in greater
detail. For example, although various pathways of endocytosis
have been described morphologically, few studies have shown
that these events are absolutely required for regulation of barrier
function. The molecular events that trigger endocytosis and how
these relate to tight junction structure are also in need of further
characterization. Nonetheless, the available data argue strongly
that the tight junction is a far more dynamic and complex struc-
ture than previously recognized. Enhanced understanding of
these processes may provide means to selectively and spe-
cifically regulate the tight junction and allow development of
targeted therapies for diverse diseases of barrier function.
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